Cholesterol-enriched membrane micro-domain deficiency induces doxorubicin resistance via promoting autophagy in breast cancer
Drug resistance has become one of the largest challenges for cancer chemotherapies. Under certain conditions, cancer cells hijack autophagy to cope with therapeutic stress, which largely undermines the chemo-therapeutic efficacy. Currently, biomarkers indicative of autophagy-derived drug resistance...
Main Authors: | Yin Shi, Zu Ye, Guang Lu, Naidi Yang, Jianbin Zhang, Liming Wang, Jianzhou Cui, Miguel A. del Pozo, Yihua Wu, Dajing Xia, Han-Ming Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Molecular Therapy: Oncolytics |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S237277052100142X |
Similar Items
-
VAMP8 phosphorylation regulates lysosome dynamics during autophagy
by: Lei Wang, et al.
Published: (2022-12-01) -
Luteolin Attenuates Doxorubicin-Induced Cardiotoxicity Through Promoting Mitochondrial Autophagy
by: Haixia Xu, et al.
Published: (2020-02-01) -
Celastrol directly binds with VAMP7 and RAB7 to inhibit autophagy and induce apoptosis in preadipocytes
by: Chenshu Liu, et al.
Published: (2023-03-01) -
snz/SNX25 at the crossroad of endocytosis and lipid handling in autophagy
by: Annie Lauzier, et al.
Published: (2022-12-01) -
Chidamide enhances cytotoxicity of doxorubicin by promoting autophagy and apoptosis in breast cancer
by: Jieqing Li
Published: (2023-04-01)